Home › Immune System and Disorders › New Jersey › Clifton
Immune System and Disorders clinical trials in Clifton, NJ
4 studies for Immune System and Disorders are looking for participants at sites in and around Clifton (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
RecruitingPhase 1
- Hackensack University Medical Center - John Theurer Cancer C - Lymphoma Division, Hackensack · 7 mi away
A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma
RecruitingPhase 1
- John Theurer Cancer Center, Hackensack University Medical Center, Hackensack · 7 mi away
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
RecruitingPhase 1/2
- John Theurer Cancer Center Hackensack University Medical Center, Hackensack · 7 mi away
Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
RecruitingPhase 2
- John Theurer Cancer Center at Hackensack University Medical Center, Hackensack · 7 mi away
About Immune System and Disorders
Your immune system is made up of cells, tissues, and organs that fight infections and diseases. Learn how it works, and about diseases of the immune system.
More about Immune System and Disorders on MedlinePlus
Immune System and Disorders trials in other cities
- Washington, DC13 studies
- New York City, NY12 studies
- Boston, MA10 studies
- Philadelphia, PA10 studies
- Portland, OR9 studies
- Atlanta, GA9 studies
- Houston, TX9 studies
- Cleveland, OH8 studies
- Los Angeles, CA8 studies
- Chicago, IL8 studies
- Milwaukee, WI6 studies
- Seattle, WA6 studies
Other studies in Clifton
- Non-Small Cell Lung Cancer24 studies
- Cancer (all types)15 studies
- Multiple Myeloma14 studies
- Metastatic Cancer12 studies
- Acute Myeloid Leukemia12 studies
- Prostate Cancer12 studies
- Breast Cancer12 studies
- Ovarian Cancer11 studies
- Lung Cancer10 studies
- Endometrial Cancer8 studies
- Triple-Negative Breast Cancer8 studies
- Colorectal Cancer8 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.